Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 29 Mar 2022 for Lineage Cell Therapeutics, Inc., €52k. Read the official filing
Filing timeline
BuySaleDipti Amin
Insider track record
Disclosed buys
1
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+34.4%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Dipti Amin: trading record in brief
Our data holds just one disclosure by Dipti Amin, dated 29 March 2022, reporting an open-market purchase worth €52k in Lineage Cell Therapeutics, Inc. Further filings will be added here. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Dipti Amin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
35,000 shares@ US$1.63100.0% of flowCommon Shares, no par valueSEC:0001493152-22-008029:0
Canonical exit: 26 Jun 2022 (T+90)
1 of 1 declaration
